At times, a tip of a peripherally inserted central catheter (“PICC”) or central venous catheter (“CVC”) can move becoming displaced from an ideal position in a patient's superior vena cava (“SVC”). A clinician believing such a PICC or CVC has displaced typically checks for displacement by chest X-ray and replaces the PICC or CVC if necessary. However, X-rays expose patients to ionizing radiation. Therefore, there is a need for clinicians to easily and safely check for displacement of PICCs and CVCs for replacement thereof if necessary.
Disclosed herein are shape-sensing systems with filters and methods thereof that address the foregoing.
Disclosed herein is a shape-sensing system including, in some embodiments, one or more medical devices including an integrated optical-fiber stylet and a heartbeat-detecting means for detecting a sequence of heartbeats, a console, and a display screen. The optical-fiber stylet has a plurality of fiber Bragg grating (“FBG”) sensors along a distal-end portion of the optical-fiber stylet. The console includes memory and one or more processors. The console is configured to convert the sequence of heartbeats into a heartbeat frequency by way of a heartbeat-converter algorithm. The console is configured to convert FBG sensor-reflected optical signals from the optical-fiber stylet into plottable data by way of a plurality of optical signal-converter algorithms. The optical signal-converter algorithms include a band-pass filtering algorithm for a selection of the FBG sensors along a distal-end portion of the optical-fiber stylet. The band-pass filtering algorithm is configured to pass therethrough the FBG sensor-reflected optical signals, or corresponding data, occurring with one or more frequencies within a range of frequencies around the heartbeat frequency while rejecting the FBG sensor-reflected optical signals, or the corresponding data, occurring with one or more frequencies outside the range of frequencies around the heartbeat frequency. The display screen is configured for displaying any plot of a plurality of plots of the plottable data. The plurality of plots include a plot of curvature vs. time for each FBG sensor of the selection of the FBG sensors for identifying periodic changes in strain of the optical-fiber stylet at a moment a tip of the optical-fiber stylet is advanced into a heart of a patient.
In some embodiments, the optical signal-converter algorithms include a band-stop filtering algorithm for the FBG sensors proximal of the selection of the FBG sensors. The band-stop filtering algorithm is configured to reject the FBG sensor-reflected optical signals, or the corresponding data, occurring with one or more frequencies within the range of frequencies around the heartbeat frequency while passing therethrough the FBG sensor-reflected optical signals, or the corresponding data, occurring with one or more frequencies outside the range of frequencies around the heartbeat frequency.
In some embodiments, the plurality of plots include a displayable shape over a 3-dimensional grid corresponding to the optical-fiber stylet in 3-dimensional space. The displayable shape is substantially free from heartbeat-related hydrodynamic noise.
In some embodiments, the heartbeat-detecting means is incorporated into a same medical device as that including the optical-fiber stylet.
In some embodiments, the same medical device including the optical-fiber stylet has electrocardiogram (“ECG”) electrodes electrically connected by a cable to ECG componentry in the console for detecting the sequence of heartbeats.
In some embodiments, the same medical device includes the optical-fiber stylet having one or more lumens configured to contain a saline solution. The medical device includes a cable to connect the one-or-more lumens when filled with the saline solution to ECG componentry in the console for detecting the sequence of heartbeats.
In some embodiments, the heartbeat-detecting means is incorporated into a different medical device than that including the optical-fiber stylet.
In some embodiments, the different medical device includes ECG skin electrodes electrically connected to ECG componentry in the console for detecting the sequence of heartbeats.
In some embodiments, the console includes a heart-determiner algorithm configured to automatically confirm on the display the tip of the optical-fiber stylet is in the heart of the patient by way of the periodic changes in the strain of the optical-fiber stylet sensed by the selection of the FBG sensors. The periodic changes in the strain resulting from heartbeat-related hydrodynamics.
In some embodiments, the shape-sensing system further includes an optical interrogator configured to send input optical signals into the optical-fiber stylet and receive the FBG sensor-reflected optical signals from the optical-fiber stylet. The optical interrogator is either a stand-alone optical interrogator or an integrated optical interrogator integrated into the console.
Also disclosed herein is a method of a shape-sensing system including, in some embodiments, a shape-sensing step of shape sensing with an optical-fiber stylet of the shape-sensing system while a tip of the optical-fiber stylet is advanced through a vasculature of a patient toward a heart. The optical-fiber stylet has a plurality of FBG sensors along a distal-end portion of the optical-fiber stylet for the shape sensing. The method further includes a detecting step of detecting a sequence of heartbeats with a heartbeat-detecting means of the shape-sensing system for detecting the sequence of heartbeats while the tip of the optical-fiber stylet is advanced through the vasculature of the patient toward the heart. The method further includes a first converting step of converting the sequence of heartbeats into a heartbeat frequency by way of a heartbeat-converter algorithm of a console of the shape-sensing system.
The method further includes a second converting step of converting FBG sensor-reflected optical signals received from the optical-fiber stylet into plottable data by way of a plurality of optical signal-converter algorithms of the console. The second converting step includes passing the FBG sensor-reflected optical signals, or corresponding data, for a selection of the FBG sensors along a distal-end portion of the optical-fiber stylet through a band-pass filtering algorithm of the optical signal-converter algorithms. The band-pass filtering algorithm is configured to pass therethrough the FBG sensor-reflected optical signals, or the corresponding data, for the selection of the FBG sensors occurring with one or more frequencies within a range of frequencies around the heartbeat frequency while rejecting the FBG sensor-reflected optical signals, or the corresponding data, occurring with one or more frequencies outside the range of frequencies around the heartbeat frequency. The method further includes a plotting step of plotting a plurality of plots including a plot of curvature vs. time for each FBG sensor of the selection of the FBG sensors on a display screen of the shape-sensing system. The method further includes a displaying step of displaying on the display screen periodic changes in strain in the plot of curvature vs. time for any FBG sensor of the selection of the FBG sensors at a moment the tip of the optical-fiber stylet is advanced into the heart of the patient.
In some embodiments, the second converting step includes passing the FBG sensor-reflected optical signals, or the corresponding data, for the FBG sensors proximal of the selection of the FBG sensors through a band-stop filtering algorithm of the optical signal-converter algorithms. The band-stop filtering algorithm is configured to reject the FBG sensor-reflected optical signals, or the corresponding data, occurring with one or more frequencies within the range of frequencies around the heartbeat frequency while passing therethrough the FBG sensor-reflected optical signals, or the corresponding data, occurring with one or more frequencies outside the range of frequencies around the heartbeat frequency.
In some embodiments, the plurality of plots includes a displayable shape over a 3-dimensional grid corresponding to the optical-fiber stylet in 3-dimensional space. The displayable shape is substantially free from heartbeat-related hydrodynamic noise.
In some embodiments, the heartbeat-detecting means includes ECG electrodes of a medical device including the optical-fiber stylet, ECG skin electrodes, or a combination thereof connected to ECG componentry in the console for detecting the sequence of heartbeats.
In some embodiments, the method further includes a signal-sending step of sending input optical signals into the optical-fiber stylet by an optical interrogator and a signal-receiving step of receiving the FBG sensor-reflected optical signals from the optical-fiber stylet with the optical interrogator. The optical interrogator being either a stand-alone optical interrogator or an integrated optical interrogator integrated into the console.
Also disclosed herein is a method for determining a tip of a medical device is located within a heart including, in some embodiments, an advancing step of advancing the tip of the medical device through a vasculature of a patient toward the heart. The medical device includes an integrated optical-fiber stylet having a plurality of FBG sensors along a distal-end portion of the optical-fiber stylet for shape sensing with a shape-sensing system including the medical device. The method further includes a detecting step of detecting a sequence of heartbeats with a heartbeat-detecting means of the shape-sensing system for detecting the sequence of heartbeats while advancing the tip of the medical device through the vasculature of the patient toward the heart. The method further includes a first allowing step of allowing the sequence of heartbeats to be converted into a heartbeat frequency by way of a heartbeat-converter algorithm of a console of the shape-sensing system.
The method further includes a second allowing step of allowing FBG sensor-reflected optical signals received from the optical-fiber stylet while advancing the tip of the medical device through the vasculature of the patient to be converted into plottable data by way of a plurality of optical signal-converter algorithms of the console. The optical signal-converter algorithms include a band-pass filtering algorithm for a selection of the FBG sensors along a distal-end portion of the optical-fiber stylet. The band-pass filtering algorithm is configured to pass therethrough the FBG sensor-reflected optical signals or corresponding data occurring with one or more frequencies within a range of frequencies around the heartbeat frequency while rejecting the FBG sensor-reflected optical signals or corresponding data occurring with one or more frequencies outside the range of frequencies around the heartbeat frequency. The method further includes a third allowing step of allowing a plurality of plots including a plot of curvature vs. time for each FBG sensor of the selection of the FBG sensors to be plotted on a display screen of the shape-sensing system. The method further includes an identifying step of identifying on the display screen periodic changes in strain in the plot of curvature vs. time for any FBG sensor of the selection of the FBG sensors at a moment the tip of the medical device is advanced into the heart of the patient, thereby determining the tip of the medical device is located within the heart.
In some embodiments, the optical signal-converter algorithms include a band-stop filtering algorithm for the FBG sensors proximal of the selection of the FBG sensors. The band-stop filtering algorithm is configured to reject the FBG sensor-reflected optical signals, or corresponding data, occurring with one or more frequencies within the range of frequencies around the heartbeat frequency while passing therethrough the FBG sensor-reflected optical signals, or the corresponding data, occurring with one or more frequencies outside the range of frequencies around the heartbeat frequency.
In some embodiments, the plurality of plots include a displayable shape over a 3-dimensional grid corresponding to the optical-fiber stylet in 3-dimensional space. The displayable shape is substantially free from heartbeat-related hydrodynamic noise.
In some embodiments, the heartbeat-detecting means includes ECG electrodes of the medical device, ECG skin electrodes, or a combination thereof connected to ECG componentry in the console for detecting the sequence of heartbeats.
In some embodiments, the advancing step includes advancing the tip of the medical device through a right internal jugular vein, a right brachiocephalic vein, and into an SVC.
In some embodiments, the optical-fiber stylet is disposed in a central venous catheter (“CVC”).
In some embodiments, the advancing step includes advancing the tip of the medical device through a right basilic vein, a right axillary vein, a right subclavian vein, a right brachiocephalic vein, and into an SVC.
In some embodiments, the medical device is a peripherally inserted central catheter (“PICC”).
In some embodiments, the method further includes a ceasing step of ceasing to advance the tip of the medical device through the vasculature of the patient after determining the tip of the medical device is located in the heart.
These and other features of the concepts provided herein will become more apparent to those of skill in the art in view of the accompanying drawings and following description, which describe particular embodiments of such concepts in greater detail.
Before some particular embodiments are disclosed in greater detail, it should be understood that the particular embodiments disclosed herein do not limit the scope of the concepts provided herein. It should also be understood that a particular embodiment disclosed herein can have features that can be readily separated from the particular embodiment and optionally combined with or substituted for features of any of a number of other embodiments disclosed herein.
Regarding terms used herein, it should also be understood the terms are for the purpose of describing some particular embodiments, and the terms do not limit the scope of the concepts provided herein. Ordinal numbers (e.g., first, second, third, etc.) are generally used to distinguish or identify different features or steps in a group of features or steps, and do not supply a serial or numerical limitation. For example, “first,” “second,” and “third” features or steps need not necessarily appear in that order, and the particular embodiments including such features or steps need not necessarily be limited to the three features or steps. Labels such as “left,” “right,” “top,” “bottom,” “front,” “back,” and the like are used for convenience and are not intended to imply, for example, any particular fixed location, orientation, or direction. Instead, such labels are used to reflect, for example, relative location, orientation, or directions. Singular forms of “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise.
With respect to “proximal,” a “proximal portion” or a “proximal-end portion” of, for example, a catheter disclosed herein includes a portion of the catheter intended to be near a clinician when the catheter is used on a patient. Likewise, a “proximal length” of, for example, the catheter includes a length of the catheter intended to be near the clinician when the catheter is used on the patient. A “proximal end” of, for example, the catheter includes an end of the catheter intended to be near the clinician when the catheter is used on the patient. The proximal portion, the proximal-end portion, or the proximal length of the catheter can include the proximal end of the catheter; however, the proximal portion, the proximal-end portion, or the proximal length of the catheter need not include the proximal end of the catheter. That is, unless context suggests otherwise, the proximal portion, the proximal-end portion, or the proximal length of the catheter is not a terminal portion or terminal length of the catheter.
With respect to “distal,” a “distal portion” or a “distal-end portion” of, for example, a catheter disclosed herein includes a portion of the catheter intended to be near or in a patient when the catheter is used on the patient. Likewise, a “distal length” of, for example, the catheter includes a length of the catheter intended to be near or in the patient when the catheter is used on the patient. A “distal end” of, for example, the catheter includes an end of the catheter intended to be near or in the patient when the catheter is used on the patient. The distal portion, the distal-end portion, or the distal length of the catheter can include the distal end of the catheter; however, the distal portion, the distal-end portion, or the distal length of the catheter need not include the distal end of the catheter. That is, unless context suggests otherwise, the distal portion, the distal-end portion, or the distal length of the catheter is not a terminal portion or terminal length of the catheter.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art.
As set forth above, there is a need for clinicians to easily and safely check for displacement of PICCs and CVCs for replacement thereof if necessary. Disclosed herein are shape-sensing systems with filters and methods thereof that address the foregoing.
For example, a shape-sensing system includes, in some embodiments, one or more medical devices including an integrated optical-fiber stylet and a heartbeat-detecting means for detecting a sequence of heartbeats, a console, and a display screen. The optical-fiber stylet has a number of FBG sensors along a distal-end portion of the optical-fiber stylet. The console includes memory and one or more processors. The console is configured to convert the sequence of heartbeats into a heartbeat frequency by way of a heartbeat-converter algorithm. The console is configured to convert FBG sensor-reflected optical signals from the optical-fiber stylet into plottable data by way of a number of optical signal-converter algorithms. The optical signal-converter algorithms include a band-pass filtering algorithm for a selection of the FBG sensors along a distal-end portion of the optical-fiber stylet. The band-pass filtering algorithm is configured to pass therethrough the FBG sensor-reflected optical signals, or corresponding data, occurring with one or more frequencies within a range of frequencies around the heartbeat frequency while rejecting the FBG sensor-reflected optical signals, or the corresponding data, occurring with one or more frequencies outside the range of frequencies around the heartbeat frequency. The display screen is configured for displaying any plot of a number of plots of the plottable data. The number of plots include a plot of curvature vs. time for each FBG sensor of the selection of the FBG sensors for identifying periodic changes in strain of the optical-fiber stylet at a moment a tip of the optical-fiber stylet is advanced into a heart of a patient.
These and other features of the shape-sensing systems with filters and methods provided herein will become more apparent with reference to the accompanying drawings and the following description, which provide particular embodiments of the shape-sensing systems with filters and methods thereof in greater detail.
Shape-Sensing Systems
As shown, the shape-sensing system 100 includes at least a medical device 110, a stand-alone optical interrogator 130, a console 140, and the display screen 150 such as that of a stand-alone monitor. The shape-sensing system 200 includes the medical device 110, an integrated optical interrogator 230, a console 240, and the display screen 250, wherein both the integrated optical interrogator 230 and the display screen 250 are integrated into the console 240. Each shape-sensing system of the shape-sensing systems 100 and 200 can further include an optical-fiber connector module 120 configured for connecting the medical device 110 to a remainder of the shape-sensing system 100 or 200 such as the optical interrogator 130 or the console 240, which includes the integrated optical interrogator 230.
As set forth in more detail below, the medical device 110 includes an integrated optical-fiber stylet having a number of FBG sensors along at least a distal-end portion of the optical-fiber stylet for shape sensing with the shape-sensing system 100 or 200. (See the optical-fiber stylet 424 in
Certain features of the medical device 110 are set forth in more detail below with respect to particular embodiments of the medical device 110 such as the PICC 310. That said, some features set forth below with respect to one or more embodiments of the medical device 110 are shared among two or more embodiments of the medical device 110. As such, “the medical device 110” is used herein to generically refer to more than one embodiment of the medical device 110 when needed for expository expediency. This is despite certain features having been described with respect to particular embodiments of the medical device 110 such as the PICC 310.
While only shown for the console 240, each console of the consoles 140 and 240 includes one or more processors 242 and memory 244 including a number of algorithms 246 such as one or more optical signal-converter algorithms including a band-pass filtering algorithm or a band-stop filtering algorithm, as well as a heartbeat-converter algorithm. The one-or-more optical signal-convertor algorithms are configured to convert the reflected optical signals from the optical-fiber stylet of the medical device 110 into plottable data for a number of plots of the plottable data. The one-or-more optical signal-converter algorithms are also configured to convert FBG sensor-reflected optical signals from the optical-fiber stylet of the medical device 110 into plottable data for a displayable shape corresponding to the medical device 110. The display screen 150 or 250 is configured to display the displayable shape for the medical device 110 over a 3-dimensional grid 1002 representing 3-dimensional space, as well as any plot of the number of plots of the other plottable data.
The number of plots can include a plot of curvature vs. arc length 1004, a plot of torsion vs. arc length 1006, a plot of angle vs. arc length 1008, or a plot of position vs. time 1010 for at least a distal-end portion of the optical-fiber stylet. The number of plots can further include at least a plot of curvature vs. time 1012a, 1012b, 1012c, . . . , 1012n, for each FBG sensor of a selection of the FBG sensors in the distal-end portion of the optical-fiber stylet. Any one or more of the plots of curvature vs. time 1012a, 1012b, 1012c, . . . , 1012n, for the selection of the FBG sensors in the distal-end portion of the optical-fiber stylet can be used to manually identify a distinctive change in strain of the optical-fiber stylet by way of a distinctive change in plotted curvature of the optical-fiber stylet at a moment a tip of the medical device 110 is advanced into a heat of a patient. However, the three plots of curvature vs. time 1012a, 1012b, and 1012c shown in
In addition to being able to use any one or more of the plots of curvature vs. time to manually identify the distinctive change in the strain of the optical-fiber stylet at the moment the tip of the medical device 110 is advanced into the heart of the patient, any one or more of the plots of curvature vs. time 1012a, 1012b, 1012c, . . . , 1012n, for the selection of the FBG sensors in the distal-end portion of the optical-fiber stylet can be used to manually confirm the tip of the medical device 110 is in the heart by way of periodic changes in the strain of the optical-fiber stylet. The periodic changes in the strain of the optical-fiber stylet are evidenced by periodic changes in the plotted curvature of the optical-fiber stylet sensed by the selection of the FBG sensors. (See the three plots of curvature vs. time 1012a, 1012b, and 1012c in
The periodic changes in the strain sensed by any FBG sensor of the selection of the FBG sensors in the distal-end portion of the optical-fiber stylet are relatively small changes. Consequently, the periodic changes in the plotted curvature for any FBG sensor of the selection of the FBG sensors are also relatively small changes. Because such relatively small changes can be easily overwhelmed, it can be helpful to enhance the periodic changes in the plotted curvatures for the selection of the FBG sensors by filtering out strain experienced by the selection of the FBG sensors other than that resulting from the periodic changes periodic changes in blood flow within the heart.
As set forth above, the one-or-more optical signal-converter algorithms of the number of algorithms 246 includes a band-pass filtering algorithm, which is configured to facilitate identifying the periodic changes in the strain sensed by the optical-fiber stylet, particularly the strain sensed by any FBG sensor of the selection of the FBG sensors at a moment the tip of the optical-fiber stylet is advanced into a heart of a patient. The one-or-more optical signal-converter algorithms of the number of algorithms 246 also includes a band-stop filtering algorithm, which is configured to support displaying the displayable shape corresponding to the medical device 110 over the 3-dimensional grid 1002 representing 3-dimensional space. Indeed, the band-stop filtering algorithm is configured to support displaying the displayable shape such that the displayable shape is substantially free from heartbeat-related hydrodynamics or noise thereof. Each algorithm of the band-pass filtering algorithm and the band-stop filtering algorithm depend in part upon heartbeat frequency, which can be obtained from a patient by way the heartbeat-detecting means for detecting a sequence of heartbeats and the heartbeat converter algorithm for converting the sequence of heartbeats into the heartbeat frequency.
The heartbeat-detecting means can be incorporated into a same medical device as that including the optical-fiber stylet, namely the medical device 110, or a different medical device than that including the optical-fiber stylet. With respect to the same medical device as that including the optical-fiber stylet, the heartbeat-detecting means can include an ECG stylet disposed in the medical device 110 or ECG electrodes of the medical device 110 electrically connected by a cable to ECG componentry in the console 140 or 240 for detecting the sequence of heartbeats. Alternatively, the heartbeat-detecting means can include one or more lumens of the medical device 110 configured to contain a saline solution in accordance with the so-called saline technique, wherein a column of saline solution contained in a catheter is used as an intracavitary electrode. In such embodiments, the medical device 110 can include a cable to connect the one-or-more lumens when filled with the saline solution to the ECG componentry in the console 140 or 240 for detecting the sequence of heartbeats. With respect to the different medical device than that including the optical-fiber stylet, the heartbeat-detecting means can include ECG skin electrodes electrically connected to the ECG componentry in the console 140 or 240 for detecting the sequence of heartbeats.
The console 140 or 240 is configured to convert the sequence of heartbeats detected by the heartbeat detecting means into an instant heartbeat frequency by way of the heartbeat-converter algorithm of the number of algorithms 246, which heartbeat frequency, in turn, can be used by the band-pass filtering algorithm, the band-stop filtering algorithm, or both. The sequence of heartbeats can be constant over time with respect to diastolic or systolic points in the sequence of heartbeats, increasing over time with respect to the diastolic or systolic points in the sequence of heartbeats, decreasing over time with respect to the diastolic or systolic points in the sequence of heartbeats, or some combination thereof. Like the sequence of heartbeats from which the heartbeat frequency is derived, the heartbeat frequency can be constant, increase over time, decrease over time, or some combination thereof.
The console 140 or 240 is configured to convert the reflected optical signals from the optical-fiber stylet of the medical device 110 into the plottable data by way of the band-pass filtering algorithm of the one-or-more optical signal-convertor algorithms using the instant heartbeat frequency provided by the heartbeat-converter algorithm. The band-pass filtering algorithm is configured to pass therethrough the FBG sensor-reflected optical signals, or corresponding data, occurring with one or more frequencies within a range of frequencies around the heartbeat frequency while rejecting the FBG sensor-reflected optical signals, or the corresponding data, occurring with one or more frequencies outside the range of frequencies around the heartbeat frequency. Filtering the FBG sensor-reflected optical signals, or the corresponding data, with the band-pass filtering algorithm facilitates identifying the periodic changes in the strain sensed by the optical-fiber stylet, particularly the strain sensed by any FBG sensor of the selection of the FBG sensors, at a moment the tip of the medical device 110 or the optical-fiber stylet thereof is advanced into a heart of a patient. As set forth above, because such relatively small changes can be easily overwhelmed, it can be helpful to enhance the periodic changes in the plotted curvatures for the selection of the FBG sensors by filtering out strain experienced by the selection of the FBG sensors other than that resulting from the periodic changes in strain.
The console 140 or 240 is also configured to convert the reflected optical signals from the optical-fiber stylet of the medical device 110 into the plottable data by way of the band-stop filtering algorithm of the one-or-more optical signal-convertor algorithms using the instant heartbeat frequency provided by the heartbeat-converter algorithm. The band-stop filtering algorithm is configured to reject the FBG sensor-reflected optical signals, or corresponding data, occurring with one or more frequencies within the range of frequencies around the heartbeat frequency while passing therethrough the FBG sensor-reflected optical signals, or the corresponding data, occurring with one or more frequencies outside the range of frequencies around the heartbeat frequency. Filtering the FBG sensor-reflected optical signals, or the corresponding data, with the band-stop filtering algorithm supports displaying the displayable shape corresponding to the medical device 110 over the 3-dimensional grid 1002 representing 3-dimensional space, particularly a portion of the medical device 110 or the optical-fiber stylet thereof having the FBG sensors proximal of the selection of the FBG sensors. Indeed, the band-stop filtering algorithm is configured to support displaying the displayable shape such that the displayable shape is substantially free from heartbeat-related hydrodynamics or noise thereof.
In some embodiments, the band-pass filtering algorithm is configured to filter the FBG sensor-reflected optical signals, or the corresponding data, for the selection of the FBG sensors (e.g., a last three FBG sensors) in the distal-end portion of the optical-fiber stylet while the band-stop filtering algorithm is configured to filter the FBG sensor-reflected optical signals, or the corresponding data, for the FBG sensors proximal of the foregoing selection of the FBG sensors. In this way, the band-pass filtering algorithm facilitates identifying the periodic changes in the strain sensed by any FBG sensor of the selection of the FBG sensors in the distal-end portion of the optical-fiber stylet while the band-stop filtering algorithm supports displaying the displayable shape corresponding to a remainder of the medical device 110 proximal of the selection of the FBG sensors.
Each console of the consoles 140 and 240 can further include a heart-determiner algorithm of the one-or-more algorithms 246 configured to automatically determine the distinctive change in the strain of the optical-fiber stylet by way of a distinctive change in plotted curvature of the optical-fiber stylet, or the plottable data therefor, at the moment the tip of the medical device 110 is advanced into the heart of the patient. Again, the distinctive change in the plotted curvature is an instantaneous increase in the plotted curvature followed by an instantaneous decrease in the plotted curvature having a magnitude about twice that of the instantaneous increase in the plotted curvature. The heart-determiner algorithm can also be configured to confirm the tip of the medical device 110 is in the heart by way of automatically determining periodic changes in the plotted curvature of the optical-fiber stylet sensed by the selection of the FBG sensors. (See the three plots of curvature vs. time 1012a, 1012b, and 1012c in
The optical interrogator 130 or 230 is configured to send input optical signals into the optical-fiber stylet of the medical device 110 and receive the reflected optical signals from the optical-fiber stylet. When the optical-fiber connector module 120 is present in the shape-sensing system 100 or 200, the optical interrogator 130 or 230 is configured to send the input optical signals into the optical-fiber stylet of the medical device 110 by way of the optical-fiber connector module 120 and receive the reflected optical signals from the optical-fiber stylet by way of the optical-fiber connector module 120.
The optical-fiber connector module 120 includes a housing 324, a cable 326 extending from the housing 324, and an optical fiber 528 within at least the cable 326. (For the optical fiber 528, see
The optical-fiber connector module 120 can further include one or more sensors 222 selected from at least a gyroscope, an accelerometer, and a magnetometer disposed within the housing 324. The one-or-more sensors 222 are configured to provide sensor data to the console 140 or 240 by way of one or more data wires within at least the cable 326 for determining a reference plane with a reference plane-determiner algorithm of the one-or-more algorithms 246 for shape sensing with the optical-fiber stylet of the medical device 110.
Certain features of the optical-fiber connector module 120 are set forth in more detail below with respect to particular embodiments of the optical-fiber connector module 120 such as the optical-fiber connector module 620 and 820. That said, some features set forth below with respect to one or more embodiments of the optical-fiber connector module 120 are shared among two or more embodiments of the optical-fiber connector module 120. As such, “the optical-fiber connector module 120” is used herein to generically refer to more than one embodiment of the optical-fiber connector module 120 when needed for expository expediency. This is despite certain features having been described with respect to particular embodiments of the optical-fiber connector module 120 such as the optical-fiber connector modules 620 and 820.
Medical Devices
As shown, the PICC 310 includes the catheter tube 312, a bifurcated hub 314, two extension legs 316, and two Luer connectors 318 operably connected in the foregoing order. The catheter tube 312 includes two catheter-tube lumens 413 and the optical-fiber stylet 424 disposed in a longitudinal bead 425 of the catheter tube 312 such as between the two catheter-tube lumens 413, as extruded. Optionally, in a same or different longitudinal bead of the catheter tube 312, the PICC 310 can further include an ECG stylet or ECG electrodes electrically connected by a cable to the ECG componentry in the console 140 or 240 for detecting the sequence of heartbeats. The bifurcated hub 314 has two hub lumens correspondingly fluidly connected to the two catheter-tube lumens 413. Each extension leg of the two extension legs 316 has an extension-leg lumen fluidly connected to a hub lumen of the two hub lumens. The PICC 310 further includes a stylet extension tube 320 extending from the bifurcated hub 314. The stylet extension tube 320 can be a skived portion of the catheter tube 312 including the optical-fiber stylet 424 or the skived portion of the catheter tube 312 disposed in another tube, either of which can terminate in a plug 322 for establishing an optical connection between the optical fiber 528 of the optical-fiber connector module 120 and the optical-fiber stylet 424 of the PICC 310.
The optical-fiber stylet 424 includes a number of FBG sensors 426a, 426b, 426c, . . . , 426n along at least a distal-end portion of the optical-fiber stylet 424 configured for shape sensing with the shape-sensing system 100 or 200. The FBG sensors 426a, 426b, 426c, . . . , 426n include periodic variations in refractive index of the optical fiber of the optical-fiber stylet 424, thereby forming wavelength-specific reflectors configured to reflect the input optical signals sent into the optical-fiber stylet 424 by the optical interrogator 130 or 230.
While the PICC 310 is provided as a particular embodiment of the medical device 110 of the shape-sensing system 100 or 200, it should be understood that any medical device of a number of medical devices including catheters such as a CVC can include at least an optical-fiber stylet and a stylet extension tube terminating in a plug for establishing an optical connection between the optical-fiber stylet of the medical device and the optical interrogator 130 or 230, optionally by way of the optical fiber 528 of the optical-fiber connector module 120.
Optical-Fiber Connector Modules
As shown, the optical-fiber connector module 620 or 820 includes the housing 324, the receptacle 532 disposed in the housing 324, the cable 326 extending from the housing 324, and the optical fiber 528 within at least the cable 326.
The receptacle 532 includes an optical receiver configured to accept insertion of an optical terminal of a plug of the medical device 110 (e.g., the plug 322 of the PICC 310) for establishing an optical connection between the optical-fiber connector module 620 or 820 and the optical-fiber stylet of the medical device 110 (e.g., the optical-fiber stylet 424 of the PICC 310) when the plug is inserted into the receptacle 532.
The cable 326 includes the plug 330 for establishing an optical connection between the optical-fiber connector module 620 or 820 and the optical interrogator 230 of the console 240.
The optical fiber 528 extends from the receptacle 532 through the cable 326 to the plug 330. The optical fiber 528 is configured to convey the input optical signals from the optical interrogator 230 to the optical-fiber stylet of the medical device 110 (e.g., the optical-fiber stylet 424 of the PICC 310) and the reflected optical signals from the optical-fiber stylet to the optical interrogator 230.
As set forth above, the optical-fiber connector module 620 or 820 can further include the one-or-more sensors 222 selected from the gyroscope, the accelerometer, and the magnetometer disposed within the housing 324. The one-or-more sensors 222 are configured to provide sensor data for determining a reference plane for shape sensing with the optical-fiber stylet of the medical device 110 (e.g., the optical-fiber stylet 424 of the PICC 310).
While not shown, the optical-fiber connector module 620 or 820 can further include power and data wires extending from the one-or-more sensors 222 through the cable 326 to the plug 330 or another plug. The power and data wires are configured to respectively convey power to the one-or-more sensors 122 and data from the one-or-more sensors 122 to the console 240 when the one-or-more sensors 122 are present in the optical-fiber connector module 620 or 820.
The optical-fiber connection module 620 is configured to sit within the fenestration 601 of the surgical drape 603 adjacent a percutaneous insertion site for the medical device 110 (e.g., a catheter such as the PICC 310). As the optical-fiber connection module 620 is configured to sit within the fenestration 601 of the surgical drape 603, the optical-fiber connection module 620 is amenable to disinfection or sterilization. For example, the housing 324 of the optical-fiber connection module 620 can be a non-porous or chemically resistant to oxidants. The optical-fiber connection module 620 can be configured for manual disinfection with a ChloraPrep product by Becton, Dickinson and Company (Franklin Lakes, N.J.), or the optical-fiber connection module 620 can be configured for automatic high-level disinfection or sterilization with vaporized H2O2 by way of Trophon® by Nanosonics Inc. (Indianapolis, Ind.).
In contrast to the optical-fiber connection module 620, the optical-fiber connection module 820 is configured to sit beneath the surgical drape 603 on a chest of a patient P. As such, the optical-fiber connection module 820 need not require a same level of disinfection or sterilization as the optical-fiber connection module 620.
While not shown, the housing 324 the optical-fiber connection module 820 includes a loop extending from the housing 324, a tether point integrated into the housing 324, a ball-lock-pin receiver integrated into the housing 324, or the like configured for attaching a neck strap to the optical-fiber connector module 820. The loop, the tether point, the ball-lock-pin receiver, or the like enables the optical-fiber connector module 820 to be secured to a neck of the patient P while sitting on the patient's chest. Additionally or alternatively, the housing 324 includes a patient-facing surface (e.g., a back of the optical-fiber connection module 820) configured to be adhered to the patient's chest. The patient-facing surface enables the optical-fiber connector module 820 to be secured to the patient's chest while sitting on the patient's chest whether or not the optical-fiber connection module 820 is also secured to the patient's neck.
Again, the receptacle 532 includes an optical receiver configured to accept insertion of an optical terminal of a plug of the medical device 110 (e.g., the plug 322 of the PICC 310) and form an optical connection when the plug is inserted into the receptacle 532; however, with the optical-fiber connector module 820, the optical connection is formed with the surgical drape 603 between the optical-fiber connector module 820 and the medical device 110. The receptacle 532 and the plug of the medical device 110 enable at least the optical connection from a sterile field (e.g., above the surgical drape 603) including the medical device 110 such as the PICC 310 to a non-sterile field (e.g., beneath the surgical drape 603) including the optical-fiber connection module 820 by way of breaching the surgical drape 603.
Methods
A method of the shape-sensing system 100 or 200 includes a shape-sensing step of shape sensing with the optical-fiber stylet (e.g., the optical-fiber stylet 424) of the shape-sensing system 100 or 200 while the tip of the medical device 110 or the optical-fiber stylet is advanced through a vasculature of a patient toward a heart.
The method further includes a detecting step of detecting a sequence of heartbeats with the heartbeat-detecting means of the shape-sensing system 100 or 200 for detecting the sequence of heartbeats while the tip of the medical device 110 of the optical-fiber stylet thereof is advanced through the vasculature of the patient toward the heart.
The method further includes a signal-sending step of sending the input optical signals into the optical-fiber stylet by the optical interrogator 130 or 230 and a signal-receiving step of receiving the FBG sensor-reflected optical signals from the optical-fiber stylet with the optical interrogator 130 or 230.
The method further includes a first converting step of converting the sequence of heartbeats into a heartbeat frequency by way of the heartbeat-converter algorithm of the console 140 or 240 of the shape-sensing system 100 or 200.
The method further includes a second converting step of converting the FBG sensor-reflected optical signals received from the optical-fiber stylet into plottable data by way of the number of optical signal-converter algorithms of the console 140 or 240.
The second converting step can include passing the FBG sensor-reflected optical signals, or the corresponding data, for the selection of the FBG sensors along the distal-end portion of the optical-fiber stylet through the band-pass filtering algorithm of the optical signal-converter algorithms. As set forth above, the band-pass filtering algorithm is configured to pass therethrough the FBG sensor-reflected optical signals, or the corresponding data, for the selection of the FBG sensors occurring with one or more frequencies within a range of frequencies around the heartbeat frequency while rejecting the FBG sensor-reflected optical signals, or the corresponding data, occurring with one or more frequencies outside the range of frequencies around the heartbeat frequency.
The second converting step can include passing the FBG sensor-reflected optical signals, or the corresponding data, for the FBG sensors proximal of the selection of the FBG sensors through the band-stop filtering algorithm of the optical signal-converter algorithms. The band-stop filtering algorithm is configured to reject the FBG sensor-reflected optical signals, or the corresponding data, occurring with one or more frequencies within the range of frequencies around the heartbeat frequency while passing therethrough the FBG sensor-reflected optical signals, or the corresponding data, occurring with one or more frequencies outside the range of frequencies around the heartbeat frequency.
The method further includes a plotting step of plotting a number of plots in view of filtering the FBG sensor-reflected optical signals, or the corresponding data, through the band-pass and band-stop filtering algorithms of the optical signal-converter algorithms. The number of plots can include a plot of curvature vs. time for each FBG sensor of the selection of the FBG sensors on the display screen 150 or 250 of the shape-sensing system 100 or 200. The number of plots can include a displayable shape over a 3-dimensional grid corresponding to the optical-fiber stylet in 3-dimensional space. The displayable shape is substantially free from heartbeat-related hydrodynamic noise.
The method further includes a displaying step of displaying on the display screen 150 or 250 the periodic changes in strain in the plot of curvature vs. time for any FBG sensor of the selection of the FBG sensors at a moment the tip of the medical device 110 or the optical-fiber stylet thereof is advanced into the heart of the patient.
Each method of a number of methods for determining whether the tip of the medical device 110 is located within a heart of a patient includes an advancing step of advancing the tip of the medical device 110 through a vasculature of the patient toward the heart. As set forth above, the medical device 110 (e.g., the PICC 310) includes the integrated optical-fiber stylet (e.g., the optical-fiber stylet 424) having the number of FBG sensors (e.g. the FBG sensors 426a, 426b, 426c, . . . , 426n) along at least the distal-end portion of the optical-fiber stylet for shape sensing with the shape-sensing system 100 or 200 including the medical device 110. When the medical device 110 is the PICC 310, the advancing step can include advancing the tip of the PICC 310 through a right basilic vein, a right axillary vein, a right subclavian vein, a right brachiocephalic vein, and into an SVC. When the medical device is a CVC, the advancing step includes advancing the tip of the CVC through a right internal jugular vein, a right brachiocephalic vein, and into the SVC.
The method can include enabling certain functions of the shape-sensing system 100 or 200 by turning on the console 140 or 240, running one or more programs on the console 140 or 240, making the selection of the FBG sensors (e.g., a selection of the FBG sensors 426a, 426b, 426c . . . , 426n) in the distal-end portion of the optical-fiber stylet for the plots of curvature vs. time 1012a, 1012b, 1012c, . . . , 1012n, making the optical or electrical connections, or the like as needed for various functions of the shape-sensing system 100 or 200.
Enabling certain functions of the shape-sensing system 100 or 200 can include a first enabling or allowing step of enabling or allowing the input optical signals to be sent into the optical-fiber stylet by the optical interrogator 130 or 230 of the shape-sensing system 100 or 200 while advancing the tip of the medical device 110 through the vasculature of the patient.
Enabling certain functions of the shape-sensing system 100 or 200 can include a second enabling or allowing step of enabling or allowing a sequence of heartbeats to be converted into a heartbeat frequency by way of the heartbeat-converter algorithm of the console 140 or 240 of the shape-sensing system 100 or 200. The second enabling or allowing step is during a detecting step of detecting the sequence of heartbeats with the heartbeat-detecting means of the shape-sensing system 100 or 200 for detecting the sequence of heartbeats while advancing the tip of the medical device 110 through the vasculature of the patient.
Enabling certain functions of the shape-sensing system 100 or 200 can include a third enabling or allowing step of enabling or allowing the FBG sensor-reflected optical signals to be received from the optical-fiber stylet by the optical interrogator 130 or 230 while advancing the tip of the medical device 110 through the vasculature of the patient.
Enabling certain functions of the shape-sensing system 100 or 200 can include a fourth enabling or allowing step of enabling or allowing the FBG sensor-reflected optical signals received from the optical-fiber stylet to be algorithmically converted into plottable data by way of the number of optical signal-converter algorithms.
The optical signal-converter algorithms can include the band-pass filtering algorithm for a selection of the FBG sensors (e.g., a last three FBG sensors) along the distal-end portion of the optical-fiber stylet. The band-pass filtering algorithm passes therethrough the FBG sensor-reflected optical signals, or the corresponding data, occurring with one or more frequencies within a range of frequencies around the heartbeat frequency while rejecting the FBG sensor-reflected optical signals or corresponding data occurring with one or more frequencies outside the range of frequencies around the heartbeat frequency.
The optical signal-converter algorithms can include the band-stop filtering algorithm for the FBG sensors proximal of the selection of the FBG sensors. The band-stop filtering algorithm rejects the FBG sensor-reflected optical signals, or the corresponding data, occurring with one or more frequencies within the range of frequencies around the heartbeat frequency while passing therethrough the FBG sensor-reflected optical signals, or the corresponding data, occurring with one or more frequencies outside the range of frequencies around the heartbeat frequency.
Enabling certain functions of the shape-sensing system 100 or 200 can include a fifth enabling or allowing step of enabling or allowing the plottable data to be plotted in a number of different plots (e.g., the plot of curvature vs. arc length 1004, the plot of torsion vs. arc length 1006, the plot of angle vs. arc length 1008, the plot of position vs. time 1010, one or more of the plots of curvature vs. time 1012a, 1012b, 1012c . . . , 1012n, etc.) on the display screen 150 or 250 of the shape-sensing system 100 or 200.
Enabling certain functions of the shape-sensing system 100 or 200 can include a sixth enabling or allowing step of enabling or allowing the FBG sensor-reflected optical signals received from the optical-fiber stylet to be algorithmically converted into the displayable shapes over the 3-dimensional grid 1002 for the medical device 110 on the display screen 150 or 250 of the shape-sensing system 100 or 200.
The method can include an identifying step of manually identifying on the display screen 150 or 250 the distinctive change in the plotted curvature of the optical-fiber stylet sensed by the selection of the FBG sensors in the distal-end portion of the optical-fiber stylet at the moment the tip of the medical device 110 is advanced into the heart, thereby determining the tip of the medical device 110 is located within the heart. The identifying step can include identifying the instantaneous increase in the plotted curvature of the optical-fiber stylet followed by the instantaneous decrease in the plotted curvature as sensed by each FBG sensor of the last three FBG sensors (e.g., the FBG sensors 426a, 426b, and 426c) in the distal-end portion of the optical-fiber stylet at the moment the tip of the medical device 110 is advanced into the heart. Additionally or alternatively, the method can include a determining step of automatically determining with the heart-determiner algorithm the distinctive change in the plotted curvature of the optical-fiber stylet, or the plottable data therefor, sensed by the selection of the FBG sensors in the distal-end portion of the optical-fiber stylet at the moment the tip of the medical device 110 is advanced into the heart.
The method can include a ceasing step of ceasing to advance the tip of the medical device 110 through the vasculature of the patient after determining the tip of the medical device 110 is located in the heart.
The method can include an identifying or confirming step of identifying or confirming the tip of the medical device 110 is in the heart by way of periodic changes in the plotted curvature of the optical-fiber stylet sensed by the selection of the FBG sensors. For example, the identifying step can include identifying on the display screen 150 or 250 the periodic changes in strain in the plot of curvature vs. time for any FBG sensor of the selection of the FBG sensors at a moment the tip of the medical device 110 is advanced into the heart of the patient, thereby determining the tip of the medical device 110 is located within the heart.
Notably, not one method of the shape-sensing system 100 or 200 requires an X-ray for determining whether the tip of the medical device 110 is located within the heart of the patient. As such, patients need not be exposed to ionizing X-ray radiation when the shape-sensing system 100 or 200 is used. In addition, not one method of the shape-sensing system 100 or 200 requires an additional magnetic-sensor piece of capital equipment for determining whether the tip of the medical device 110 is located within the heart of the patient. In addition, since, the shape-sensing system 100 or 200 does not require use of a reliable ECG P-wave like some existing systems for placing a tip of a medical device into a heart of a patient, the shape-sensing system 100 or 200 can be used with patient having atrial fibrillation or another heart arrhythmia.
While some particular embodiments have been disclosed herein, and while the particular embodiments have been disclosed in some detail, it is not the intention for the particular embodiments to limit the scope of the concepts provided herein. Additional adaptations and/or modifications can appear to those of ordinary skill in the art, and, in broader aspects, these adaptations and/or modifications are encompassed as well. Accordingly, departures may be made from the particular embodiments disclosed herein without departing from the scope of the concepts provided herein.
This application is a continuation of U.S. patent application Ser. No. 17/105,259, filed Nov. 25, 2020, now U.S. Pat. No. 11,525,670, which claims the benefit of priority to U.S. Provisional Application No. 62/940,100, filed Nov. 25, 2019, each of which is incorporated by reference in its entirety into this application.
Number | Name | Date | Kind |
---|---|---|---|
4813429 | Eshel et al. | Mar 1989 | A |
5099845 | Besz et al. | Mar 1992 | A |
5163935 | Black et al. | Nov 1992 | A |
5207672 | Roth et al. | May 1993 | A |
5211165 | Dumoulin et al. | May 1993 | A |
5275151 | Shockey et al. | Jan 1994 | A |
5280786 | Wlodarczyk et al. | Jan 1994 | A |
5423321 | Fontenot | Jun 1995 | A |
5454807 | Lennox et al. | Oct 1995 | A |
5460182 | Goodman et al. | Oct 1995 | A |
5517997 | Fontenot | May 1996 | A |
5622170 | Schulz | Apr 1997 | A |
5740808 | Panescu et al. | Apr 1998 | A |
5872879 | Hamm | Feb 1999 | A |
5873842 | Brennen et al. | Feb 1999 | A |
5879306 | Fontenot et al. | Mar 1999 | A |
5906579 | Vander Salm et al. | May 1999 | A |
6069698 | Ozawa et al. | May 2000 | A |
6081741 | Hollis | Jun 2000 | A |
6178346 | Amundson et al. | Jan 2001 | B1 |
6208887 | Clarke | Mar 2001 | B1 |
6319227 | Mansouri-Ruiz | Nov 2001 | B1 |
6343227 | Crowley | Jan 2002 | B1 |
6398721 | Nakamura et al. | Jun 2002 | B1 |
6485482 | Belef | Nov 2002 | B1 |
6564089 | Izatt et al. | May 2003 | B2 |
6593884 | Gilboa et al. | Jul 2003 | B1 |
6597941 | Fontenot et al. | Jul 2003 | B2 |
6650923 | Lesh et al. | Nov 2003 | B1 |
6685666 | Fontenot | Feb 2004 | B1 |
6687010 | Horii et al. | Feb 2004 | B1 |
6690966 | Rava et al. | Feb 2004 | B1 |
6701181 | Tang et al. | Mar 2004 | B2 |
6711426 | Benaron et al. | Mar 2004 | B2 |
6816743 | Moreno et al. | Nov 2004 | B2 |
6892090 | Verard et al. | May 2005 | B2 |
6895267 | Panescu et al. | May 2005 | B2 |
7132645 | Kom | Nov 2006 | B2 |
7273056 | Wilson et al. | Sep 2007 | B2 |
7344533 | Pearson et al. | Mar 2008 | B2 |
7366562 | Dukesherer et al. | Apr 2008 | B2 |
7366563 | Kleen et al. | Apr 2008 | B2 |
7396354 | Rychnovsky et al. | Jul 2008 | B2 |
7406346 | Kleen et al. | Jul 2008 | B2 |
7515265 | Alfano et al. | Apr 2009 | B2 |
7532920 | Ainsworth et al. | May 2009 | B1 |
7587236 | Demos et al. | Sep 2009 | B2 |
7603166 | Casscells, III et al. | Oct 2009 | B2 |
7729735 | Burchman | Jun 2010 | B1 |
7757695 | Wilson et al. | Jul 2010 | B2 |
7758499 | Adler | Jul 2010 | B2 |
7840253 | Tremblay et al. | Nov 2010 | B2 |
7992573 | Wilson et al. | Aug 2011 | B2 |
8032200 | Tearney et al. | Oct 2011 | B2 |
8054469 | Nakabayashi et al. | Nov 2011 | B2 |
8060187 | Marshik-Geurts et al. | Nov 2011 | B2 |
8073517 | Burchman | Dec 2011 | B1 |
8078261 | Imam | Dec 2011 | B2 |
8187189 | Jung et al. | May 2012 | B2 |
8267932 | Baxter et al. | Sep 2012 | B2 |
8369932 | Cinbis et al. | Feb 2013 | B2 |
8388541 | Messerly et al. | Mar 2013 | B2 |
8571640 | Holman | Oct 2013 | B2 |
8597315 | Snow et al. | Dec 2013 | B2 |
8700358 | Parker, Jr. | Apr 2014 | B1 |
8781555 | Burnside et al. | Jul 2014 | B2 |
8798721 | Dib | Aug 2014 | B2 |
8968331 | Sochor | Mar 2015 | B1 |
8979871 | Tyc et al. | Mar 2015 | B2 |
9060687 | Yamanaka et al. | Jun 2015 | B2 |
9114226 | Lash et al. | Aug 2015 | B1 |
9360630 | Jenner et al. | Jun 2016 | B2 |
9504392 | Caron et al. | Nov 2016 | B2 |
9560954 | Jacobs et al. | Feb 2017 | B2 |
9622706 | Dick et al. | Apr 2017 | B2 |
9678275 | Griffin | Jun 2017 | B1 |
10231753 | Burnside et al. | Mar 2019 | B2 |
10258240 | Eberle et al. | Apr 2019 | B1 |
10327830 | Grant et al. | Jun 2019 | B2 |
10349890 | Misener et al. | Jul 2019 | B2 |
10492876 | Anastassiou et al. | Dec 2019 | B2 |
10568586 | Begin et al. | Feb 2020 | B2 |
10631718 | Petroff et al. | Apr 2020 | B2 |
10992078 | Thompson et al. | Apr 2021 | B2 |
11123047 | Jaffer et al. | Sep 2021 | B2 |
11525670 | Messerly | Dec 2022 | B2 |
20020198457 | Tearney et al. | Dec 2002 | A1 |
20030092995 | Thompson | May 2003 | A1 |
20040242995 | Maschke | Dec 2004 | A1 |
20050033264 | Redinger | Feb 2005 | A1 |
20050261598 | Banet et al. | Nov 2005 | A1 |
20050278010 | Richardson | Dec 2005 | A1 |
20060013523 | Childlers et al. | Jan 2006 | A1 |
20060015136 | Besselink | Jan 2006 | A1 |
20060036164 | Wilson et al. | Feb 2006 | A1 |
20060189959 | Schneiter | Aug 2006 | A1 |
20060200049 | Leo et al. | Sep 2006 | A1 |
20060241395 | Kruger et al. | Oct 2006 | A1 |
20060241492 | Boese et al. | Oct 2006 | A1 |
20070156019 | Larkin et al. | Jul 2007 | A1 |
20070201793 | Askins et al. | Aug 2007 | A1 |
20070287886 | Saadat | Dec 2007 | A1 |
20070299425 | Waner et al. | Dec 2007 | A1 |
20080039715 | Wilson et al. | Feb 2008 | A1 |
20080082004 | Banet et al. | Apr 2008 | A1 |
20080172119 | Yamasaki et al. | Jul 2008 | A1 |
20080183128 | Morriss et al. | Jul 2008 | A1 |
20080212082 | Froggatt et al. | Sep 2008 | A1 |
20080285909 | Younge et al. | Nov 2008 | A1 |
20080319290 | Mao et al. | Dec 2008 | A1 |
20090054908 | Zand et al. | Feb 2009 | A1 |
20090062634 | Say et al. | Mar 2009 | A1 |
20090118612 | Grunwald et al. | May 2009 | A1 |
20090137952 | Ramamurthy et al. | May 2009 | A1 |
20090234328 | Cox et al. | Sep 2009 | A1 |
20090304582 | Rousso et al. | Dec 2009 | A1 |
20090314925 | Van Vorhis et al. | Dec 2009 | A1 |
20100016729 | Futrell | Jan 2010 | A1 |
20100030063 | Lee et al. | Feb 2010 | A1 |
20100114115 | Schlesinger et al. | May 2010 | A1 |
20100286531 | Ryan et al. | Nov 2010 | A1 |
20100312095 | Jenkins et al. | Dec 2010 | A1 |
20110060229 | Hulvershorn et al. | Mar 2011 | A1 |
20110144481 | Feer et al. | Jun 2011 | A1 |
20110166442 | Sarvazyan | Jul 2011 | A1 |
20110172680 | Younge et al. | Jul 2011 | A1 |
20110237958 | Onimura | Sep 2011 | A1 |
20110242532 | McKenna | Oct 2011 | A1 |
20110245662 | Eggers et al. | Oct 2011 | A1 |
20110295108 | Cox et al. | Dec 2011 | A1 |
20110313280 | Govari et al. | Dec 2011 | A1 |
20120046562 | Powers et al. | Feb 2012 | A1 |
20120065481 | Hunter et al. | Mar 2012 | A1 |
20120101413 | Beetel et al. | Apr 2012 | A1 |
20120136242 | Qi et al. | May 2012 | A1 |
20120143029 | Silverstein et al. | Jun 2012 | A1 |
20120184827 | Shwartz et al. | Jul 2012 | A1 |
20120184955 | Pivotto et al. | Jul 2012 | A1 |
20120289783 | Duindam et al. | Nov 2012 | A1 |
20120321243 | Younge et al. | Dec 2012 | A1 |
20130028554 | Wong et al. | Jan 2013 | A1 |
20130072943 | Parmar | Mar 2013 | A1 |
20130096482 | Bertrand et al. | Apr 2013 | A1 |
20130104884 | Vazales et al. | May 2013 | A1 |
20130188855 | Desjardins et al. | Jul 2013 | A1 |
20130204124 | Duindam et al. | Aug 2013 | A1 |
20130211246 | Parasher | Aug 2013 | A1 |
20130296693 | Wenzel et al. | Nov 2013 | A1 |
20130310668 | Young | Nov 2013 | A1 |
20130317372 | Eberle et al. | Nov 2013 | A1 |
20130324840 | Zhongping et al. | Dec 2013 | A1 |
20140121468 | Eichenholz | May 2014 | A1 |
20140221829 | Maitland et al. | Aug 2014 | A1 |
20140275997 | Chopra et al. | Sep 2014 | A1 |
20150029511 | 'T Hooft et al. | Jan 2015 | A1 |
20150031987 | Pameijer et al. | Jan 2015 | A1 |
20150080688 | Cinbis et al. | Mar 2015 | A1 |
20150099979 | Caves et al. | Apr 2015 | A1 |
20150119700 | Liang et al. | Apr 2015 | A1 |
20150164571 | Saadat | Jun 2015 | A1 |
20150190221 | Schaefer et al. | Jul 2015 | A1 |
20150209113 | Burkholz et al. | Jul 2015 | A1 |
20150209117 | Flexman | Jul 2015 | A1 |
20150254526 | Denissen | Sep 2015 | A1 |
20150320977 | Vitullo et al. | Nov 2015 | A1 |
20160018602 | Govari et al. | Jan 2016 | A1 |
20160067449 | Misener et al. | Mar 2016 | A1 |
20160166326 | Bakker et al. | Jun 2016 | A1 |
20160166341 | Iordachita et al. | Jun 2016 | A1 |
20160184020 | Kowalewski et al. | Jun 2016 | A1 |
20160213432 | Flexman et al. | Jul 2016 | A1 |
20160354038 | Demirtas et al. | Dec 2016 | A1 |
20170020394 | Harrington | Jan 2017 | A1 |
20170079681 | Burnside | Mar 2017 | A1 |
20170082806 | Van Der Mark et al. | Mar 2017 | A1 |
20170173349 | Pfleiderer et al. | Jun 2017 | A1 |
20170196479 | Liu et al. | Jul 2017 | A1 |
20170201036 | Cohen et al. | Jul 2017 | A1 |
20170215973 | Flexman et al. | Aug 2017 | A1 |
20170231699 | Flexman et al. | Aug 2017 | A1 |
20170273542 | Au | Sep 2017 | A1 |
20170273565 | Ma et al. | Sep 2017 | A1 |
20170273628 | Ofek et al. | Sep 2017 | A1 |
20170290563 | Cole et al. | Oct 2017 | A1 |
20170311901 | Zhao | Nov 2017 | A1 |
20170319279 | Fish | Nov 2017 | A1 |
20180095231 | Lowell et al. | Apr 2018 | A1 |
20180113038 | Janabi-Sharifi et al. | Apr 2018 | A1 |
20180140170 | Van Putten et al. | May 2018 | A1 |
20180235709 | Donhowe et al. | Aug 2018 | A1 |
20180239124 | Naruse et al. | Aug 2018 | A1 |
20180240237 | Donhowe et al. | Aug 2018 | A1 |
20180250088 | Brennan et al. | Sep 2018 | A1 |
20180264227 | Flexman et al. | Sep 2018 | A1 |
20180279909 | Noonan et al. | Oct 2018 | A1 |
20180289390 | Amorizzo et al. | Oct 2018 | A1 |
20180289927 | Messerly | Oct 2018 | A1 |
20180339134 | Leo | Nov 2018 | A1 |
20180360545 | Cole et al. | Dec 2018 | A1 |
20190059743 | Ramachandran et al. | Feb 2019 | A1 |
20190110844 | Misener et al. | Apr 2019 | A1 |
20190231272 | Yamaji | Aug 2019 | A1 |
20190237902 | Thompson et al. | Aug 2019 | A1 |
20190307331 | Saadat et al. | Oct 2019 | A1 |
20190321110 | Grunwald et al. | Oct 2019 | A1 |
20190343424 | Blumenkranz et al. | Nov 2019 | A1 |
20190357875 | Qi et al. | Nov 2019 | A1 |
20190374130 | Bydlon et al. | Dec 2019 | A1 |
20200030575 | Bogusky et al. | Jan 2020 | A1 |
20200046434 | Graetzel et al. | Feb 2020 | A1 |
20200054399 | Duindam et al. | Feb 2020 | A1 |
20200305983 | Yampolsky et al. | Oct 2020 | A1 |
20200315770 | Dupont et al. | Oct 2020 | A1 |
20210015470 | Prisco et al. | Jan 2021 | A1 |
20210023341 | Decheek et al. | Jan 2021 | A1 |
20210045814 | Thompson et al. | Feb 2021 | A1 |
20210068911 | Walker et al. | Mar 2021 | A1 |
20210298680 | Sowards et al. | Mar 2021 | A1 |
20210244311 | Zhao et al. | Aug 2021 | A1 |
20210268229 | Sowards et al. | Sep 2021 | A1 |
20210271035 | Sowards et al. | Sep 2021 | A1 |
20210275257 | Prior et al. | Sep 2021 | A1 |
20210401456 | Cox et al. | Dec 2021 | A1 |
20210401509 | Misener et al. | Dec 2021 | A1 |
20210402144 | Messerly | Dec 2021 | A1 |
20220011192 | Misener et al. | Jan 2022 | A1 |
20220034733 | Misener et al. | Feb 2022 | A1 |
20220096796 | McLaughlin et al. | Mar 2022 | A1 |
20220110695 | Sowards et al. | Apr 2022 | A1 |
20220152349 | Sowards et al. | May 2022 | A1 |
20220160209 | Sowards et al. | May 2022 | A1 |
20220172354 | Misener et al. | Jun 2022 | A1 |
20220211442 | McLaughlin et al. | Jul 2022 | A1 |
20220233246 | Misener et al. | Jul 2022 | A1 |
20220369934 | Sowards et al. | Nov 2022 | A1 |
20230081198 | Sowards et al. | Mar 2023 | A1 |
20230097431 | Sowards et al. | Mar 2023 | A1 |
20230101030 | Misener et al. | Mar 2023 | A1 |
20230126813 | Sowards et al. | Apr 2023 | A1 |
20230243715 | Misener et al. | Aug 2023 | A1 |
20230248444 | Misener et al. | Aug 2023 | A1 |
20230251150 | Misener et al. | Aug 2023 | A1 |
20230337985 | Sowards et al. | Oct 2023 | A1 |
20230414112 | Misener et al. | Dec 2023 | A1 |
20240000515 | Misener et al. | Jan 2024 | A1 |
20240050708 | Misener | Feb 2024 | A1 |
20240099659 | Sowards et al. | Mar 2024 | A1 |
20240108856 | Messerly | Apr 2024 | A1 |
20240216077 | Thompson et al. | Jul 2024 | A1 |
Number | Date | Country |
---|---|---|
111265309 | Jun 2020 | CN |
113080937 | Jul 2021 | CN |
102016109601 | Nov 2017 | DE |
2240111 | Oct 2010 | EP |
2907445 | Aug 2015 | EP |
3545849 | Oct 2019 | EP |
3705020 | Sep 2020 | EP |
20190098512 | Aug 2019 | KR |
9964099 | Dec 1999 | WO |
2006113394 | Oct 2006 | WO |
2006122001 | Nov 2006 | WO |
2007002323 | Jan 2007 | WO |
2009155325 | Dec 2009 | WO |
2011121516 | Oct 2011 | WO |
2011141830 | Nov 2011 | WO |
2011150376 | Dec 2011 | WO |
2012064769 | May 2012 | WO |
2015044930 | Apr 2015 | WO |
2015074045 | May 2015 | WO |
2016038492 | Mar 2016 | WO |
2016061431 | Apr 2016 | WO |
2016051302 | Apr 2016 | WO |
2018096491 | May 2018 | WO |
2019037071 | Feb 2019 | WO |
2019046769 | Mar 2019 | WO |
2019070423 | Apr 2019 | WO |
2019230713 | Dec 2019 | WO |
2020182997 | Sep 2020 | WO |
2021030092 | Feb 2021 | WO |
2021108688 | Jun 2021 | WO |
2021108697 | Jun 2021 | WO |
2021138096 | Jul 2021 | WO |
2021216089 | Oct 2021 | WO |
2022031613 | Feb 2022 | WO |
2022081723 | Apr 2022 | WO |
2022150411 | Jul 2022 | WO |
2022164902 | Aug 2022 | WO |
2022245987 | Nov 2022 | WO |
2023043954 | Mar 2023 | WO |
2023049443 | Mar 2023 | WO |
2023055810 | Apr 2023 | WO |
2023076143 | May 2023 | WO |
2023211752 | Nov 2023 | WO |
2024006384 | Jan 2024 | WO |
2024006441 | Jan 2024 | WO |
2024064334 | Mar 2024 | WO |
Entry |
---|
Dziuda L et al: “Monitoring Respiration and Cardiac Activity Using Fiber Bragg Grating-Based Sensor”, IEEE Transactions on Biomedical Engineering vol. 59, No. 7, Jul. 2012 pp. 1934-1942. |
Dziuda L. et al: “Fiber-optic sensor for monitoring respiration and cardiac activity”, 2011 IEEE Sensors Proceedings : Limerick, Ireland, Oct. 2011 pp. 413-416. |
EP 20893677.3 filed Jun. 22, 2022 Extended European Search Report dated Oct. 13, 2023. |
EP 20894633.5 filed Jun. 22, 2022 Extended European Search Report dated Oct. 16, 2023. |
PCT/US2023/026581 filed Jun. 29, 2023 International Search Report and Written Opinion dated Oct. 27, 2023. |
PCT/US2023/033471 filed Sep. 22, 2023 International Search Report and Written Opinion dated Dec. 21, 2023. |
U..S. Appl. No. 16/984,104, filed Aug. 3, 2020 Notice of Allowance dated Nov. 21, 2023. |
U.S. Appl. No. 17/500,678, filed Oct. 13, 2021 Advisory Action dated Dec. 7, 2023. |
U.S. Appl. No. 17/500,678, filed Oct. 13, 2021 Non-Final Office Action dated Jan. 19, 2024. |
U.S. Appl. No. 18/135,337, filed Apr. 17, 2023 Non-Final Office Action dated Dec. 22, 2023. |
U.S. Appl. No. 17/569,350, filed Jan. 5, 2022 Non-Final Office Action dated Jan. 8, 2024. |
Fiber Optic RealShape (FORS) technology—research. Philips. (Oct. 18, 2018). Retrieved Feb. 28, 2023, from https:// www.philips.com/a-w/research/research-programs/fors.html (Year: 2018). |
U..S. Appl. No. 16/984,104, filed Aug. 3, 2020 Restriction Requirement dated Mar. 13, 2023. |
U.S. Appl. No. 17/105,310, filed Nov. 25, 2020 Non-Final Office Action dated Feb. 22, 2023. |
U.S. Appl. No. 17/357,186, filed Jun. 24, 2021 Restriction Requirement dated Mar. 7, 2023. |
U.S. Appl. No. 17/392,002, filed Aug. 2, 2021, Corrected Notice of Allowability dated Feb. 23, 2023. |
U.S. Appl. No. 17/500,678, filed Oct. 13, 2021 Non-Final Office Action dated Mar. 15, 2023. |
EP 20853352.1 filed Mar. 7, 2022 Extended European Search Report dated Jul. 27, 2023. |
PCT/US2021/052046 filed Sep. 24, 2021 International Search Report and Written Opinion dated Jan. 11, 2022. |
PCT/US2023/019239 filed Apr. 20, 2023 International Search Report and Written Opinion dated Jul. 20, 2023. |
PCT/US2023/026487 filed Jun. 28, 2023 International Search Report and Written Opinion dated Sep. 6, 2023. |
U.S. Appl. No. 16/984,104, filed Aug. 3, 2020 Final Office Action dated Sep. 21, 2023. |
U.S. Appl. No. 16/984,104, filed Aug. 3, 2020 Non-Final Office Action dated Jun. 22, 2023. |
U.S. Appl. No. 17/105,310, filed Nov. 25, 2020 Notice of Allowance dated Aug. 2, 2023. |
U.S. Appl. No. 17/357,186, filed Jun. 24, 2021 Non Final Office Action dated May 30, 2023. |
U.S. Appl. No. 17/357,186, filed Jun. 24, 2021 Notice of Allowance dated Aug. 23, 2023. |
U.S. Appl. No. 17/484,960, filed Sep. 24, 2021 Non-Final Office Action dated Oct. 5, 2023. |
U.S. Appl. No. 17/500,678, filed Oct. 13, 2021 Final Office Action dated Sep. 21, 2023. |
Jackle Sonja et al. “Three-dimensional guidance including shape sensing of a stentgraft system for endovascular aneurysm repair.” International Journal of Computer Assisted Radiology and Surgery, Springer DE. vol. 15, No. 6, May 7, 2020. |
PCT/US2018/026493 filed Apr. 6, 2018 International Search Report and Written Opinion dated Jun. 22, 2018. |
PCT/US2020/044801 filed Aug. 3, 2020 International Search Report and Written Opinion dated Oct. 26, 2020. |
PCT/US2020/062396 filed Nov. 25, 2020 International Preliminary Report on Patentability dated Jan. 29, 2021. |
PCT/US2020/062396 filed Nov. 25, 2020 International Search Report and Written Opinion dated Mar. 2, 2021. |
PCT/US2020/062407 filed Nov. 25, 2020 International Preliminary Report on Patentability dated Jan. 25, 2021. |
PCT/US2020/062407 filed Nov. 25, 2020 International Search Report and Written Opinion dated Mar. 11, 2021. |
PCT/US2021/038899 filed Jun. 24, 2021 International Search Report and Written Opinion dated Oct. 6, 2021. |
PCT/US2021/038954 filed Jun. 24, 2021 International Search Report and Written Opinion dated Oct. 28, 2021. |
PCT/US2021/041128 filed Jul. 9, 2021 International Search Report and Written Opinion dated Oct. 25, 2021. |
PCT/US2021/044216 filed Aug. 2, 2021 International Search Report and Written Opinion dated Nov. 18, 2021. |
PCT/US2021/054802 filed Oct. 13, 2021 International Search Report and Written Opinion dated Feb. 2, 2022. |
PCT/US2022/011347 filed Jan. 5, 2022 International Search Report and Written Opinion dated May 3, 2022. |
PCT/US2022/013897 filed Jan. 26, 2022 International Search Report and Written Opinion dated May 11, 2022. |
PCT/US2022/029894 filed May 18, 2022, International Search Report and Written Opinion dated Sep. 1, 2022. |
PCT/US2022/043706 filed Sep. 16, 2022 International Search Report and Written Opinion dated Nov. 24, 2022. |
PCT/US2022/044696 filed Sep. 26, 2022 International Search Report and Written Opinion dated Jan. 23, 2023. |
PCT/US2022/045051 filed Sep. 28, 2022 International Search Report and Written Opinion dated Jan. 2, 2023. |
PCT/US2022/047538 filed Oct. 24, 2022 International Search Report and Written Opinion dated Jan. 26, 2023. |
U.S. Appl. No. 15/947,267, filed Apr. 6, 2018 Examiner's Answer dated Novemeber 28, 2022. |
U.S. Appl. No. 15/947,267, filed Apr. 6, 2018 Final Office Action dated Apr. 22, 2022. |
U.S. Appl. No. 17/105,259, filed Nov. 25, 2020, Notice of Allowance dated Jul. 20, 2022. |
U.S. Appl. No. 17/357,561, filed Jun. 24, 2021 Non-Final Office Action dated Aug. 11, 2022. |
U.S. Appl. No. 17/357,561, filed Jun. 24, 2021 Notice of Allowance dated Dec. 9, 2022. |
U.S. Appl. No. 17/371,993, filed Jul. 9, 2021 Non-Final Office Action dated Jul. 12, 2022. |
U.S. Appl. No. 17/371,993, filed Jul. 9, 2021 Notice of Allowance dated Nov. 3, 2022. |
U.S. Appl. No. 17/392,002, filed Aug. 2, 2021, Non-Final Office Action dated Sep. 12, 2022. |
U.S. Appl. No. 17/392,002, filed Aug. 2, 2021, Notice of Allowance dated Jan. 19, 2023. |
U.S. Appl. No. 15/947,267, filed Apr. 6, 2018 Final Office Action dated Jun. 30, 2021. |
U.S. Appl. No. 15/947,267, filed Apr. 6, 2018 Final Office Action dated Nov. 10, 2020. |
U.S. Appl. No. 15/947,267, filed Apr. 6, 2018 Non-Final Office Action dated Mar. 12, 2021. |
U.S. Appl. No. 15/947,267, filed Apr. 6, 2018 Non-Final Office Action dated May 29, 2020. |
U.S. Appl. No. 15/947,267, filed Apr. 6, 2018 Non-Final Office Action dated Oct. 13, 2021. |
U.S. Appl. No. 15/947,267, filed Apr. 6, 2018 Notice of Allowance dated Jul. 16, 2024. |
U.S. Appl. No. 17/569,350, filed Jan. 5, 2022 Advisory Action dated Jul. 12, 2024. |
U.S. Appl. No. 17/955,019, filed Sep. 28, 2022 Restriction Requirement dated Jun. 6, 2024. |
U.S. Appl. No. 18/132,231, filed Apr. 7, 2023 Non-Final Office Action dated Jul. 12, 2024. |
U.S. Appl. No. 17/971,873, filed Oct. 24, 2022 Non-Final Office Action dated Jun. 6, 2024. |
U.S. Appl. No. 17/484,960, filed Sep. 24, 2021 Notice of Allowance dated Apr. 12, 2024. |
U.S. Appl. No. 17/569,350, filed Jan. 5, 2022 Final Office Action dated Apr. 23, 2024. |
U.S. Appl. No. 17/747,903, filed May 18, 2022 Restriction Requirement dated May 28, 2024. |
U.S. Appl. No. 18/132,623, filed Apr. 10, 2023, Non-Final Office Action dated May 3, 2024. |
U.S. Appl. No. 18/135,337, filed Apr. 17, 2023 Notice of Allowance dated Mar. 8, 2024. |
Number | Date | Country | |
---|---|---|---|
20230108604 A1 | Apr 2023 | US |
Number | Date | Country | |
---|---|---|---|
62940100 | Nov 2019 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17105259 | Nov 2020 | US |
Child | 18079653 | US |